Annalisa graduated in Medical Biotechnology (BSc) at the University of Milan (Italy) in July 2012 and in Neurobiology (MSc) at the University of Pavia (Italy) with a thesis on the role of the synapse protein SNAP-25 in neurological disorders, under the supervision of Professor Michela Matteoli (Humanitas Institute). After one year of fellowship, she started her PhD program in Neuroscience under the supervision of Dr. Laura Cancedda and Dr. Marco De Vivo at IIT. During these 3 years she focused on the discovery and characterization of a novel drug candidate, which resulted in ameliorating core symptoms in Down syndrome and autism models. She obtained her PhD in Neuroscience in February 2019 from University of Genoa (Italy). Then, she obtained a position of Post Doc at Fondazione Telethon, affiliated to the Brain Development & Disease lab at IIT, to plan and perform further preclinical analysis for the development of the drug candidate toward advanced preclinical phases.
Recently, she has been awarded by a Postdoctoral Fellowship from Jerome Lejeune Foundation to study epilepsy in Down syndrome, hosted by Brain Development & Disease lab at IIT.
Annalisa expertise include in vivo transfection of nucleic acids (in utero electroporation), in vitro and in vivo pharmacology, biochemistry and cell/molecular biology, rodent behavioral testing. In addition to her technical expertise, she has writing and editing experience.